title: Regulatory innovation and drug development for early-stage Alzheimer's disease.
authors.affiliation: Division of Neurology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Kozauer
authors.forename: Russell
authors.initials: R
authors.lastname: Katz
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D016229:Amyloid beta-Peptides / Q000187:drug effects / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D055808:Drug Discovery / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers